Major Musculoskeletal Pain Markets Forecast to Reach $5.39 Billion by 2034 - Insights on Epidemiology, Pipeline Drugs, Trends, Unmet Needs, Sales, Major Players, and More
13 juin 2024 05h00 HE
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Generalized Anxiety Disorder Market 2024-2034: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast
23 mai 2024 05h58 HE
|
Research and Markets
Dublin, May 23, 2024 (GLOBE NEWSWIRE) -- The "Generalized Anxiety Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Global $45.38 Billion Analgesics Market Insights, Competitive Landscape, and Market Forecasts, 2022-2023 & 2027
18 avr. 2023 10h03 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Analgesics - Market Insights, Competitive Landscape, and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering.The...
Global Duloxetine API Market Size - Forecasts to 2026 | GME
13 oct. 2020 10h46 HE
|
Global Market Estimates
BROOKLYN, New York, Oct. 13, 2020 (GLOBE NEWSWIRE) -- As per the new market research report published by Global Market Estimates, the Global Duloxetine API Market will grow at a CAGR estimation of...
OWP Pharmaceuticals Announces Patent Application for the First-Ever Powder for Oral Liquid Formulation of Duloxetine Hydrochloride for the Treatment of Major Depressive and Generalized Anxiety Disorder
08 juil. 2020 08h00 HE
|
OWP Pharmaceuticals
NAPERVILLE, Ill., July 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Fibromyalgia Treatment Market to Surpass US$ 3,607.3 Million by 2026 – Coherent Market Insights
10 mai 2019 08h35 HE
|
CMI
SEATTLE, May 10, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the fibromyalgia treatment market was valued at US$ 2,778.6 million in 2018 and is projected to exhibit a CAGR of...